Skip to main navigation Skip to search Skip to main content

Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies

  • Gert Jan Timmers
  • , Dannis G van Vuurden
  • , Eleonora L Swart
  • , Alberdina M Simoons-Smit
  • , Peter C Huijgens

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Cefpirome, a fourth generation cephalosporin, was administered during 154 episodes of febrile neutropenia in 106 patients. We assessed the clinical efficacy of cefpirome and its activity against isolated pathogens in neutropenic patients with hematologic malignancies. In addition, the pharmacokinetics and optimal dosing regimen of cefpirome during neutropenia were investigated.

Original languageEnglish
Pages (from-to)1005-6
Number of pages2
JournalHaematologica
Volume90
Issue number7
Publication statusPublished - Jul 2005
Externally publishedYes

Keywords

  • Aged
  • Anti-Bacterial Agents/therapeutic use
  • Cephalosporins/therapeutic use
  • Female
  • Fever/drug therapy
  • Hematologic Neoplasms/drug therapy
  • Humans
  • Male
  • Middle Aged
  • Neutropenia/drug therapy

Fingerprint

Dive into the research topics of 'Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies'. Together they form a unique fingerprint.

Cite this